Advertisement

Mx genes: host determinants controlling influenza virus infection and trans-species transmission

  • Otto HallerEmail author
  • Georg Kochs
Review
  • 86 Downloads
Part of the following topical collections:
  1. Human genetics of infectious diseases

Abstract

The human MxA protein, encoded by the interferon-inducible MX1 gene, is an intracellular influenza A virus (IAV) restriction factor. It can protect transgenic mice from severe IAV-induced disease, indicating a key role of human MxA for host survival and suggesting that natural variations in MX1 may account for inter-individual differences in disease severity among humans. MxA also provides a robust barrier against zoonotic transmissions of avian and swine IAV strains. Therefore, zoonotic IAV must acquire MxA escape mutations to achieve sustained human-to-human transmission. Here, we discuss recent progress in the field.

Notes

Acknowledgments

We thank Heinz Arnheiter, Laura Graf, Martin Schwemmle, and Peter Staeheli for excellent comments on the manuscript.

Funding

This work was funded by grants of the Deutsche Forschungsgemeinschaft to G.K. (Ko 1579/8-2 and 1579/9-2).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. Accola MA, Huang B, Al Masri A, McNiven MA (2002) The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum. J Biol Chem 277:21829–21835.  https://doi.org/10.1074/jbc.M201641200 CrossRefPubMedGoogle Scholar
  2. Aebi M, Fah J, Hurt N, Samuel CE, Thomis D, Bazzigher L, Pavlovic J, Haller O, Staeheli P (1989) cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol 9:5062–5072.  https://doi.org/10.1128/mcb.9.11.5062 CrossRefPubMedPubMedCentralGoogle Scholar
  3. Allen EK, Randolph AG, Bhangale T, Dogra P, Ohlson M, Oshansky CM, Zamora AE, Shannon JP, Finkelstein D, Dressen A, DeVincenzo J, Caniza M, Youngblood B, Rosenberger CM, Thomas PG (2017) SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. Nat Med 23:975–983.  https://doi.org/10.1038/nm.4370 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Arnheiter H, Skuntz S, Noteborn M, Chang S, Meier E (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62:51–61CrossRefGoogle Scholar
  5. Asano A, Jin HK, Watanabe T (2003) Mouse Mx2 gene: organization, mRNA expression and the role of the interferon-response promoter in its regulation. Gene 306:105–113CrossRefGoogle Scholar
  6. Ashenberg O, Padmakumar J, Doud MB, Bloom JD (2017) Deep mutational scanning identifies sites in influenza nucleoprotein that affect viral inhibition by MxA. PLoS Pathog 13:e1006288.  https://doi.org/10.1371/journal.ppat.1006288 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Benfield CT, Lyall JW, Kochs G, Tiley LS (2008) Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays. J Virol 82:7533–7539.  https://doi.org/10.1128/JVI.00185-08 CrossRefPubMedPubMedCentralGoogle Scholar
  8. Bernasconi D, Schultz U, Staeheli P (1995) The interferon-induced Mx protein of chickens lacks antiviral activity. J Interferon Cytokine Res 15:47–53.  https://doi.org/10.1089/jir.1995.15.47 CrossRefPubMedGoogle Scholar
  9. Bigham AW, Buckingham KJ, Husain S, Emond MJ, Bofferding KM, Gildersleeve H, Rutherford A, Astakhova NM, Perelygin AA, Busch MP, Murray KO, Sejvar JJ, Green S, Kriesel J, Brinton MA, Bamshad M (2011) Host genetic risk factors for West Nile virus infection and disease progression. PLoS One 6:e24745.  https://doi.org/10.1371/journal.pone.0024745 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, Casanova JL (2012) Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol 24:364–378.  https://doi.org/10.1016/j.coi.2012.04.011 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Bradley KC, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Fuchs SY, Staeheli P, Wack A (2019) Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell Rep 28(245–256):e4.  https://doi.org/10.1016/j.celrep.2019.05.105 CrossRefGoogle Scholar
  12. Cao B, Liu X, Hou F, Li W, Han Z, Zhang Q, Dai Y, Xu C, Qi H (2009) The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population. Liver Int 29:1383–1388.  https://doi.org/10.1111/j.1478-3231.2009.02053.x CrossRefPubMedGoogle Scholar
  13. Casanova JL, Abel L (2018) Human genetics of infectious diseases: unique insights into immunological redundancy. Semin Immunol 36:1–12.  https://doi.org/10.1016/j.smim.2017.12.008 CrossRefPubMedGoogle Scholar
  14. Chen Y, Zhang L, Graf L, Yu B, Liu Y, Kochs G, Zhao Y, Gao S (2017) Conformational dynamics of dynamin-like MxA revealed by single-molecule FRET. Nat Commun 8:15744.  https://doi.org/10.1038/ncomms15744 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Ching JC, Chan KY, Lee EH, Xu MS, Ting CK, So TM, Sham PC, Leung GM, Peiris JS, Khoo US (2010) Significance of the myxovirus resistance A (MxA) gene − 23C > a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection. J Infect Dis 201:1899–1908.  https://doi.org/10.1086/652799 CrossRefPubMedGoogle Scholar
  16. Ciancanelli MJ, Huang SX, Luthra P, Garner H, Itan Y, Volpi S, Lafaille FG, Trouillet C, Schmolke M, Albrecht RA, Israelsson E, Lim HK, Casadio M, Hermesh T, Lorenzo L, Leung LW, Pedergnana V, Boisson B, Okada S, Picard C, Ringuier B, Troussier F, Chaussabel D, Abel L, Pellier I, Notarangelo LD, Garcia-Sastre A, Basler CF, Geissmann F, Zhang SY, Snoeck HW, Casanova JL (2015) Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348:448–453.  https://doi.org/10.1126/science.aaa1578 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Ciancanelli MJ, Abel L, Zhang SY, Casanova JL (2016) Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol 38:109–120.  https://doi.org/10.1016/j.coi.2015.12.002 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Ciencewicki JM, Wang X, Marzec J, Serra ME, Bell DA, Polack FP, Kleeberger SR (2014) A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection. FASEB J 28:1947–1956.  https://doi.org/10.1096/fj.13-239855 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Colon-Thillet R, Hsieh E, Graf L, McLaughlin RN Jr, Young JM, Kochs G, Emerman M, Malik HS (2019) Combinatorial mutagenesis of rapidly evolving residues yields super-restrictor antiviral proteins. PLoS Biol 17:e3000181.  https://doi.org/10.1371/journal.pbio.3000181 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Davis D, Yuan H, Liang FX, Yang YM, Westley J, Petzold C, Dancel-Manning K, Deng Y, Sall J, Sehgal PB (2019) Human antiviral protein MxA forms novel metastable membrane-less cytoplasmic condensates exhibiting rapid reversible tonicity-driven phase transitions. J Virol.  https://doi.org/10.1128/JVI.01014-19 CrossRefPubMedGoogle Scholar
  21. Deeg CM, Hassan E, Mutz P, Rheinemann L, Gotz V, Magar L, Schilling M, Kallfass C, Nurnberger C, Soubies S, Kochs G, Haller O, Schwemmle M, Staeheli P (2017) In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein. J Exp Med 214:1239–1248.  https://doi.org/10.1084/jem.20161033 CrossRefPubMedPubMedCentralGoogle Scholar
  22. Dick A, Graf L, Olal D, von der Malsburg A, Gao S, Kochs G, Daumke O (2015) Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity. J Biol Chem 290:12779–12792.  https://doi.org/10.1074/jbc.M115.650325 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Dittmann J, Stertz S, Grimm D, Steel J, Garcia-Sastre A, Haller O, Kochs G (2008) Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol 82:3624–3631.  https://doi.org/10.1128/JVI.01753-07 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Dornfeld D, Dudek AH, Vausselin T, Gunther SC, Hultquist JF, Giese S, Khokhlova-Cubberley D, Chew YC, Pache L, Krogan NJ, Garcia-Sastre A, Schwemmle M, Shaw ML (2018) SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses. Sci Rep 8:2092.  https://doi.org/10.1038/s41598-018-20458-2 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Dornfeld D, Petric PP, Hassan E, Zell R, Schwemmle M (2019) Eurasian Avian-like swine influenza A viruses escape human MxA restriction through distinct mutations in their nucleoprotein. J Virol.  https://doi.org/10.1128/JVI.00997-18 CrossRefPubMedPubMedCentralGoogle Scholar
  26. Duc TT, Farnir F, Michaux C, Desmecht D, Cornet A (2012) Detection of new biallelic polymorphisms in the human MxA gene. Mol Biol Rep 39:8533–8538.  https://doi.org/10.1007/s11033-012-1708-7 CrossRefPubMedGoogle Scholar
  27. Engelhardt OG, Sirma H, Pandolfi PP, Haller O (2004) Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. J Gen Virol 85:2315–2326.  https://doi.org/10.1099/vir.0.79795-0 CrossRefPubMedGoogle Scholar
  28. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, Gen II, Investigators M, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484:519–523.  https://doi.org/10.1038/nature10921 CrossRefPubMedPubMedCentralGoogle Scholar
  29. Ferris MT, Aylor DL, Bottomly D, Whitmore AC, Aicher LD, Bell TA, Bradel-Tretheway B, Bryan JT, Buus RJ, Gralinski LE, Haagmans BL, McMillan L, Miller DR, Rosenzweig E, Valdar W, Wang J, Churchill GA, Threadgill DW, McWeeney SK, Katze MG, Pardo-Manuel de Villena F, Baric RS, Heise MT (2013) Modeling host genetic regulation of influenza pathogenesis in the collaborative cross. PLoS Pathog 9:e1003196.  https://doi.org/10.1371/journal.ppat.1003196 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Gao S, von der Malsburg A, Paeschke S, Behlke J, Haller O, Kochs G, Daumke O (2010) Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 465:502–506.  https://doi.org/10.1038/nature08972 CrossRefPubMedGoogle Scholar
  31. Gao S, von der Malsburg A, Dick A, Faelber K, Schroder GF, Haller O, Kochs G, Daumke O (2011) Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. Immunity 35:514–525.  https://doi.org/10.1016/j.immuni.2011.07.012 CrossRefPubMedGoogle Scholar
  32. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368:1888–1897.  https://doi.org/10.1056/NEJMoa1304459 CrossRefPubMedGoogle Scholar
  33. Gerardin JA, Baise EA, Pire GA, Leroy MP, Desmecht DJ (2004) Genomic structure, organisation, and promoter analysis of the bovine (Bos taurus) Mx1 gene. Gene 326:67–75CrossRefGoogle Scholar
  34. Gotz V, Magar L, Dornfeld D, Giese S, Pohlmann A, Hoper D, Kong BW, Jans DA, Beer M, Haller O, Schwemmle M (2016) Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import. Sci Rep 6:23138.  https://doi.org/10.1038/srep23138 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Graf L, Dick A, Sendker F, Barth E, Marz M, Daumke O, Kochs G (2018) Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity. J Biol Chem 293:3056–3072.  https://doi.org/10.1074/jbc.M117.812784 CrossRefPubMedPubMedCentralGoogle Scholar
  36. Guenet JL, Bonhomme F (2003) Wild mice: an ever-increasing contribution to a popular mammalian model. Trends Genet 19:24–31CrossRefGoogle Scholar
  37. Haller O, Acklin M, Staeheli P (1987) Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies. J Interferon Res 7:647–656CrossRefGoogle Scholar
  38. Haller O, Frese M, Rost D, Nuttall PA, Kochs G (1995) Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J Virol 69:2596–2601PubMedPubMedCentralGoogle Scholar
  39. Haller O, Stertz S, Kochs G (2007) The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect 9:1636–1643.  https://doi.org/10.1016/j.micinf.2007.09.010 CrossRefPubMedGoogle Scholar
  40. Haller O, Staeheli P, Schwemmle M, Kochs G (2015) Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol 23:154–163.  https://doi.org/10.1016/j.tim.2014.12.003 CrossRefPubMedGoogle Scholar
  41. Haller O, Arnheiter H, Pavlovic J, Staeheli P (2018) The discovery of the antiviral resistance gene Mx: a story of great ideas, great failures, and some success. Annu Rev Virol 5:33–51.  https://doi.org/10.1146/annurev-virology-092917-043525 CrossRefPubMedGoogle Scholar
  42. Hamano E, Hijikata M, Itoyama S, Quy T, Phi NC, Long HT, Ha LD, Ban VV, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T, Keicho N (2005) Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun 329:1234–1239.  https://doi.org/10.1016/j.bbrc.2005.02.101 CrossRefPubMedGoogle Scholar
  43. He J, Feng D, de Vlas SJ, Wang H, Fontanet A, Zhang P, Plancoulaine S, Tang F, Zhan L, Yang H, Wang T, Richardus JH, Habbema JD, Cao W (2006) Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis 6:106.  https://doi.org/10.1186/1471-2334-6-106 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Hefti HP, Frese M, Landis H, Di Paolo C, Aguzzi A, Haller O, Pavlovic J (1999) Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol 73:6984–6991PubMedPubMedCentralGoogle Scholar
  45. Hernandez N, Melki I, Jing H, Habib T, Huang SSY, Danielson J, Kula T, Drutman S, Belkaya S, Rattina V, Lorenzo-Diaz L, Boulai A, Rose Y, Kitabayashi N, Rodero MP, Dumaine C, Blanche S, Lebras MN, Leung MC, Mathew LS, Boisson B, Zhang SY, Boisson-Dupuis S, Giliani S, Chaussabel D, Notarangelo LD, Elledge SJ, Ciancanelli MJ, Abel L, Zhang Q, Marr N, Crow YJ, Su HC, Casanova JL (2018) Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency. J Exp Med 215:2567–2585.  https://doi.org/10.1084/jem.20180628 CrossRefPubMedPubMedCentralGoogle Scholar
  46. Hijikata M, Ohta Y, Mishiro S (2000) Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Intervirology 43:124–127.  https://doi.org/10.1159/000025035 CrossRefPubMedGoogle Scholar
  47. Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, Weidmann M, Casanova JL, Haller O, Kochs G (2007) Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 81:7776–7785.  https://doi.org/10.1128/JVI.00546-06 CrossRefPubMedPubMedCentralGoogle Scholar
  48. Horisberger MA, Wathelet M, Szpirer J, Szpirer C, Islam Q, Levan G, Huez G, Content J (1988) cDNA cloning and assignment to chromosome 21 of IFI-78 K gene, the human equivalent of murine Mx gene. Somat Cell Mol Genet 14:123–131CrossRefGoogle Scholar
  49. Hug H, Costas M, Staeheli P, Aebi M, Weissmann C (1988) Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol Cell Biol 8:3065–3079CrossRefGoogle Scholar
  50. Iwasaki A (2016) Antiviral responses of inbred mice. Nat Rev Immunol 16:339.  https://doi.org/10.1038/nri.2016.44 CrossRefPubMedGoogle Scholar
  51. Jimah JR, Hinshaw JE (2019) Structural Insights into the mechanism of dynamin superfamily proteins. Trends Cell Biol 29:257–273.  https://doi.org/10.1016/j.tcb.2018.11.003 CrossRefPubMedGoogle Scholar
  52. Jin HK, Yamashita T, Ochiai K, Haller O, Watanabe T (1998) Characterization and expression of the Mx1 gene in wild mouse species. Biochem Genet 36:311–322CrossRefGoogle Scholar
  53. Klinkhammer J, Schnepf D, Ye L, Schwaderlapp M, Gad HH, Hartmann R, Garcin D, Mahlakoiv T, Staeheli P (2018) IFN-lambda prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife 7:e33354.  https://doi.org/10.7554/eLife.33354 CrossRefPubMedPubMedCentralGoogle Scholar
  54. Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, Wright M, Chiaramonte M, Graves M, Thomas HC, Hill AV, Thursz MR (2003) Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 4:411–419.  https://doi.org/10.1038/sj.gene.6363984 CrossRefPubMedGoogle Scholar
  55. Kochs G, Haller O (1999) Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc Natl Acad Sci USA 96:2082–2086CrossRefGoogle Scholar
  56. Kochs G, Janzen C, Hohenberg H, Haller O (2002) Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci USA 99:3153–3158.  https://doi.org/10.1073/pnas.052430399 CrossRefPubMedGoogle Scholar
  57. Kong XF, Zhang XX, Gong QM, Gao J, Zhang SY, Wang L, Xu J, Han Y, Jin GD, Jiang JH, Zhang DH, Lu ZM (2007) MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment. J Interferon Cytokine Res 27:809–818.  https://doi.org/10.1089/jir.2006.0163 CrossRefPubMedGoogle Scholar
  58. Lee S, Ishitsuka A, Noguchi M, Hirohama M, Fujiyasu Y, Petric PP, Schwemmle M, Staeheli P, Nagata K, Kawaguchi A (2019) Influenza restriction factor MxA functions as inflammasome sensor in the respiratory epithelium. Sci Immunol.  https://doi.org/10.1126/sciimmunol.aau4643 CrossRefPubMedGoogle Scholar
  59. Leist SR, Pilzner C, van den Brand JM, Dengler L, Geffers R, Kuiken T, Balling R, Kollmus H, Schughart K (2016) Influenza H3N2 infection of the collaborative cross founder strains reveals highly divergent host responses and identifies a unique phenotype in CAST/EiJ mice. BMC Genomics 17:143.  https://doi.org/10.1186/s12864-016-2483-y CrossRefPubMedPubMedCentralGoogle Scholar
  60. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, Exome Aggregation C (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285–291.  https://doi.org/10.1038/nature19057 CrossRefPubMedPubMedCentralGoogle Scholar
  61. Lim HK, Huang SXL, Chen J, Kerner G, Gilliaux O, Bastard P, Dobbs K, Hernandez N, Goudin N, Hasek ML, Garcia Reino EJ, Lafaille FG, Lorenzo L, Luthra P, Kochetkov T, Bigio B, Boucherit S, Rozenberg F, Vedrinne C, Keller MD, Itan Y, Garcia-Sastre A, Celard M, Orange JS, Ciancanelli MJ, Meyts I, Zhang Q, Abel L, Notarangelo LD, Snoeck HW, Casanova JL, Zhang SY (2019) Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med.  https://doi.org/10.1084/jem.20181621 CrossRefPubMedGoogle Scholar
  62. Manz B, Dornfeld D, Gotz V, Zell R, Zimmermann P, Haller O, Kochs G, Schwemmle M (2013) Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog 9:e1003279.  https://doi.org/10.1371/journal.ppat.1003279 CrossRefPubMedPubMedCentralGoogle Scholar
  63. Maurizio PL, Ferris MT, Keele GR, Miller DR, Shaw GD, Whitmore AC, West A, Morrison CR, Noll KE, Plante KS, Cockrell AS, Threadgill DW, Pardo-Manuel de Villena F, Baric RS, Heise MT, Valdar W (2018) Bayesian diallel analysis reveals Mx1-dependent and Mx1-independent effects on response to influenza A virus in mice. G3 (Bethesda) 8:427–445.  https://doi.org/10.1534/g3.117.300438 CrossRefGoogle Scholar
  64. Mills TC, Rautanen A, Elliott KS, Parks T, Naranbhai V, Ieven MM, Butler CC, Little P, Verheij T, Garrard CS, Hinds C, Goossens H, Chapman S, Hill AV (2014) IFITM3 and susceptibility to respiratory viral infections in the community. J Infect Dis 209:1028–1031.  https://doi.org/10.1093/infdis/jit468 CrossRefPubMedGoogle Scholar
  65. Mitchell PS, Patzina C, Emerman M, Haller O, Malik HS, Kochs G (2012) Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. Cell Host Microbe 12:598–604.  https://doi.org/10.1016/j.chom.2012.09.005 CrossRefPubMedPubMedCentralGoogle Scholar
  66. Mitchell PS, Emerman M, Malik HS (2013) An evolutionary perspective on the broad antiviral specificity of MxA. Curr Opin Microbiol 16:493–499.  https://doi.org/10.1016/j.mib.2013.04.005 CrossRefPubMedPubMedCentralGoogle Scholar
  67. Mitchell PS, Young JM, Emerman M, Malik HS (2015) Evolutionary analyses suggest a function of mxb immunity proteins beyond lentivirus restriction. PLoS Pathog 11:e1005304.  https://doi.org/10.1371/journal.ppat.1005304 CrossRefPubMedPubMedCentralGoogle Scholar
  68. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P (2008) Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4:e1000151.  https://doi.org/10.1371/journal.ppat.1000151 CrossRefPubMedPubMedCentralGoogle Scholar
  69. Nigg PE, Pavlovic J (2015) Oligomerization and GTP-binding requirements of MxA for viral target recognition and antiviral activity against influenza A virus. J Biol Chem 290:29893–29906.  https://doi.org/10.1074/jbc.M115.681494 CrossRefPubMedPubMedCentralGoogle Scholar
  70. Nurnberger C, Zimmermann V, Gerhardt M, Staeheli P (2016) Influenza virus susceptibility of wild-derived CAST/EiJ mice results from two amino acid changes in the MX1 restriction factor. J Virol 90:10682–10692.  https://doi.org/10.1128/JVI.01213-16 CrossRefPubMedPubMedCentralGoogle Scholar
  71. Patzina C, Haller O, Kochs G (2014) Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus. J Biol Chem 289:6020–6027.  https://doi.org/10.1074/jbc.M113.543892 CrossRefPubMedPubMedCentralGoogle Scholar
  72. Pavlovic J, Zurcher T, Haller O, Staeheli P (1990) Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 64:3370–3375PubMedPubMedCentralGoogle Scholar
  73. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, Ernst B, Kolb E, Staeheli P, Haller O (1995) Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol 69:4506–4510PubMedPubMedCentralGoogle Scholar
  74. Pillai PS, Molony RD, Martinod K, Dong H, Pang IK, Tal MC, Solis AG, Bielecki P, Mohanty S, Trentalange M, Homer RJ, Flavell RA, Wagner DD, Montgomery RR, Shaw AC, Staeheli P, Iwasaki A (2016) Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science 352:463–466.  https://doi.org/10.1126/science.aaf3926 CrossRefPubMedPubMedCentralGoogle Scholar
  75. Qi F, Yang A, Ambreen S, Bai X, Hou Y, Lu X (2019) Birth and death of Mx genes and the presence/absence of genes regulating Mx transcription are correlated with the diversity of anti-pathogenicity in vertebrate species. Mol Genet Genom 294:121–133.  https://doi.org/10.1007/s00438-018-1490-x CrossRefGoogle Scholar
  76. Reeves RH, O’Hara BF, Pavan WJ, Gearhart JD, Haller O (1988) Genetic mapping of the Mx influenza virus resistance gene within the region of mouse chromosome 16 that is homologous to human chromosome 21. J Virol 62:4372–4375PubMedPubMedCentralGoogle Scholar
  77. Reichelt M, Stertz S, Krijnse-Locker J, Haller O, Kochs G (2004) Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic 5:772–784.  https://doi.org/10.1111/j.1600-0854.2004.00219.x CrossRefPubMedGoogle Scholar
  78. Rennie ML, McKelvie SA, Bulloch EM, Kingston RL (2014) Transient dimerization of human MxA promotes GTP hydrolysis, resulting in a mechanical power stroke. Structure 22:1433–1445.  https://doi.org/10.1016/j.str.2014.08.015 CrossRefPubMedGoogle Scholar
  79. Riegger D, Hai R, Dornfeld D, Manz B, Leyva-Grado V, Sanchez-Aparicio MT, Albrecht RA, Palese P, Haller O, Schwemmle M, Garcia-Sastre A, Kochs G, Schmolke M (2015) The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. J Virol 89:2241–2252.  https://doi.org/10.1128/JVI.02406-14 CrossRefPubMedGoogle Scholar
  80. Schneider WM, Chevillotte MD, Rice CM (2014) Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32:513–545.  https://doi.org/10.1146/annurev-immunol-032713-120231 CrossRefPubMedPubMedCentralGoogle Scholar
  81. Schusser B, Reuter A, von der Malsburg A, Penski N, Weigend S, Kaspers B, Staeheli P, Hartle S (2011) Mx is dispensable for interferon-mediated resistance of chicken cells against influenza A virus. J Virol 85:8307–8315.  https://doi.org/10.1128/JVI.00535-11 CrossRefPubMedPubMedCentralGoogle Scholar
  82. Sologuren I, Martinez-Saavedra MT, Sole-Violan J, de Oliveira EDB Jr., Betancor E, Casas I, Oleaga-Quintas C, Martinez-Gallo M, Zhang SY, Pestano J, Colobran R, Herrera-Ramos E, Perez C, Lopez-Rodriguez M, Ruiz-Hernandez JJ, Franco N, Ferrer JM, Bilbao C, Andujar-Sanchez M, Alvarez Fernandez M, Ciancanelli MJ, de Castro FR, Casanova JL, Bustamante J, Rodriguez-Gallego C (2018) Lethal Influenza in two related adults with inherited GATA2 deficiency. J Clin Immunol 38:513–526CrossRefGoogle Scholar
  83. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O (1988) Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 8:4518–4523CrossRefGoogle Scholar
  84. Stertz S, Reichelt M, Krijnse-Locker J, Mackenzie J, Simpson JC, Haller O, Kochs G (2006) Interferon-induced, antiviral human MxA protein localizes to a distinct subcompartment of the smooth endoplasmic reticulum. J Interferon Cytokine Res 26:650–660.  https://doi.org/10.1089/jir.2006.26.650 CrossRefPubMedGoogle Scholar
  85. Suzuki F, Arase Y, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Takagi K, Satoh J, Kumada H (2004) Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat 11:271–276.  https://doi.org/10.1111/j.1365-2893.2004.00509.x CrossRefPubMedGoogle Scholar
  86. Tazi-Ahnini R, di Giovine FS, McDonagh AJ, Messenger AG, Amadou C, Cox A, Duff GW, Cork MJ (2000) Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region. Hum Genet 106:639–645PubMedGoogle Scholar
  87. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, Haller O, Garcia-Sastre A, Staeheli P (2007) The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81:10818–10821.  https://doi.org/10.1128/JVI.01116-07 CrossRefPubMedPubMedCentralGoogle Scholar
  88. Van Dam P, Desmecht D, Garigliany MM, Bui Tran Anh D, Van Laere AS (2019) Anti-influenza a virus activities of type I/III interferons-induced Mx1 GTPases from different mammalian species. J Interferon Cytokine Res 39:274–282.  https://doi.org/10.1089/jir.2018.0157 CrossRefGoogle Scholar
  89. Vanlaere I, Vanderrijst A, Guenet JL, De Filette M, Libert C (2008) Mx1 causes resistance against influenza A viruses in the Mus spretus-derived inbred mouse strain SPRET/Ei. Cytokine 42:62–70.  https://doi.org/10.1016/j.cyto.2008.01.013 CrossRefPubMedGoogle Scholar
  90. Verhelst J, Parthoens E, Schepens B, Fiers W, Saelens X (2012) Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. J Virol 86:13445–13455.  https://doi.org/10.1128/JVI.01682-12 CrossRefPubMedPubMedCentralGoogle Scholar
  91. von der Malsburg A, Abutbul-Ionita I, Haller O, Kochs G, Danino D (2011) Stalk domain of the dynamin-like MxA GTPase protein mediates membrane binding and liposome tubulation via the unstructured L4 loop. J Biol Chem 286:37858–37865.  https://doi.org/10.1074/jbc.M111.249037 CrossRefPubMedPubMedCentralGoogle Scholar
  92. Williams DE, Wu WL, Grotefend CR, Radic V, Chung C, Chung YH, Farzan M, Huang IC (2014) IFITM3 polymorphism rs12252-C restricts influenza A viruses. PLoS One 9:e110096.  https://doi.org/10.1371/journal.pone.0110096 CrossRefPubMedPubMedCentralGoogle Scholar
  93. Wisskirchen C, Ludersdorfer TH, Muller DA, Moritz E, Pavlovic J (2011a) The cellular RNA helicase UAP56 is required for prevention of double-stranded RNA formation during influenza A virus infection. J Virol 85:8646–8655.  https://doi.org/10.1128/JVI.02559-10 CrossRefPubMedPubMedCentralGoogle Scholar
  94. Wisskirchen C, Ludersdorfer TH, Muller DA, Moritz E, Pavlovic J (2011b) Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49. J Biol Chem 286:34743–34751.  https://doi.org/10.1074/jbc.M111.251843 CrossRefPubMedPubMedCentralGoogle Scholar
  95. Xiao H, Killip MJ, Staeheli P, Randall RE, Jackson D (2013) The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J Virol 87:13053–13058.  https://doi.org/10.1128/JVI.02220-13 CrossRefPubMedPubMedCentralGoogle Scholar
  96. Xuan Y, Wang LN, Li W, Zi HR, Guo Y, Yan WJ, Chen XB, Wei PM (2015) IFITM3 rs12252 T > C polymorphism is associated with the risk of severe influenza: a meta-analysis. Epidemiol Infect 143:2975–2984.  https://doi.org/10.1017/S0950268815000278 CrossRefPubMedGoogle Scholar
  97. Zani A, Yount JS (2018) Antiviral Protection by IFITM3 In Vivo. Curr Clin Microbiol Rep 5:229–237.  https://doi.org/10.1007/s40588-018-0103-0 CrossRefPubMedPubMedCentralGoogle Scholar
  98. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, Yan HP, Wu H, Liu JH, Liu N, Wang DY, Shu YL, Ho LP, Kellam P, McMichael A, Dong T (2013) Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 4:1418.  https://doi.org/10.1038/ncomms2433 CrossRefPubMedPubMedCentralGoogle Scholar
  99. Zhang X, Xu H, Chen X, Li X, Wang X, Ding S, Zhang R, Liu L, He C, Zhuang L, Li H, Zhang P, Yang H, Li T, Liu W, Cao W (2014) Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection. Hum Genet 133:187–197.  https://doi.org/10.1007/s00439-013-1367-3 CrossRefPubMedGoogle Scholar
  100. Zhang SY, Jouanguy E, Zhang Q, Abel L, Puel A, Casanova JL (2019) Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. Curr Opin Immunol 59:88–100.  https://doi.org/10.1016/j.coi.2019.03.008 CrossRefPubMedGoogle Scholar
  101. Zimmermann P, Manz B, Haller O, Schwemmle M, Kochs G (2011) The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol 85:8133–8140.  https://doi.org/10.1128/JVI.00712-11 CrossRefPubMedPubMedCentralGoogle Scholar
  102. Zurcher T, Pavlovic J, Staeheli P (1992) Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J 11:1657–1661CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institute of Virology, Medical CenterUniversity of FreiburgFreiburgGermany
  2. 2.Faculty of MedicineUniversity of FreiburgFreiburgGermany
  3. 3.Institute of Molecular Life SciencesUniversity of ZurichZurichSwitzerland

Personalised recommendations